USFDA concludes inspection at Unit-1 of Shilpa Medicare’s arm in Raichur

08 Mar 2025 Evaluate

The U.S Food and Drug Administration (USFDA) has conducted an inspection at Unit-1 of Shilpa Medicare’s wholly owned subsidiary--Shilpa Pharma Lifesciences, located at Raichur from March 3, 2025 to March 7, 2025. 

On conclusion of inspection, the company received 1 observation in form 483, which is procedural in nature. The company will closely work with the agency and remain committed to address this observation comprehensively within stipulated time.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.


Shilpa Medicare Share Price

663.00 -20.05 (-2.94%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...